
CHINA NATIONAL PHARMACEUTICAL FOREIGN TRADE CORPORATION (SINOPHARM Foreign Trade) provides international trade and economic & technological cooperation across pharmaceuticals, medical devices, and related health products, backed by extensive global networks and joint-venture experience.
CHINA NATIONAL PHARMACEUTICAL FOREIGN TRADE CORPORATION (SINOPHARM Foreign Trade) is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM). Established in 1981, it focuses on international pharmaceutical economic and technological cooperation, international trade, and domestic sales in pharmaceuticals and related products.
As a trade bridge connecting China with global markets, the company exports Chinese pharmaceutical products and technology while importing high-quality products and advanced technology from overseas. Its trade scope covers pharmaceutical raw materials, Western and traditional Chinese medicinal preparations, traditional Chinese medicinal materials, pharma-chemical bulks, intermediates, biological products, medical instruments, sanitary materials, as well as pharmaceutical technology and apparatus.
The company has been active in large-scale international pharmaceutical exhibitions and participates in international and domestic pharmaceutical tenders. It also undertakes nationally entrusted work such as national assistance projects, UN assistance projects to China, and national medicine reservation. With a broad corporate network that includes multiple subsidiaries, branches, joint ventures, and overseas offices, it supports wide-ranging international cooperation and long-term global engagement.
The company maintains close cooperative relationships with over one thousand companies and enterprises in more than one hundred countries and regions, supporting wide-ranging pharmaceutical trade and collaboration.
Since 1991, the company has remained among China’s top 500 enterprises by import and export volume.
The company has introduced advanced technology and equipment for technological restructuring in domestic pharmaceutical enterprises, co-invested with large foreign pharmaceutical companies, and established Sino-foreign pharmaceutical joint ventures, including China Otsuka Pharmaceutical Ltd. and Xian-Janssen Pharmaceuticals Ltd.
Envoyez une demande pour en savoir plus sur leurs capacités et obtenir des devis personnalisés.